References
- Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl. 2009;30(1):1–9. doi:10.2164/jandrol.108.00648618772485
- Dohle GR, Arver S, Bettochi C, Kliesch S, Punab M, de Ronde W. Guidelines on male hypogonadism. Eur Assoc Urol. 2012;(4):1–28.
- Moncada I. Testosterone and men’s quality of life. Aging Male. 2006;9(4):189–193. doi:10.1080/1368553060100318017178553
- Wylie K, Rees M, Hackett G, et al. Anfrogens, health and sexuality in women and men. Human Fertility. 2010;13:277–297.
- Kang H-Y. Beyond the male sex hormone: deciphering the metabolic and vascular actions of testosterone. J Endocrinol. 2013;217(3):C1–C3. doi:10.1530/JOE-13-005223528478
- Laaksonen DE, Niskanen L, Punnonen K, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003;149(6):601–608.14641004
- Pye SR, Huhtaniemi IT, Finn JD, et al. Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab. 2014;99(4):1357–1366. doi:10.1210/jc.2013-205224423283
- Cai X, Tian Y, Wu T, Cao C-X, Li H, Wang K-J. Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Asian J Androl. 2014;16(1):146–152. doi:10.4103/1008-682X.12234624369149
- Gould DC. A novel metered-dose 2% testosterone gel treatment for male hypogonadism. J Mens Health Gend. 2007;4(4):419–427. doi:10.1016/j.jmhg.2007.07.044
- Szeinbach SL, Seoane-Vazquez E, Summers KH. Development of a men’s Preference for Testosterone Replacement Therapy (P-TRT) instrument. Patient Prefer Adher. 2012;6:631–641. doi:10.2147/PPA.S35840
- Arver S, Stief C, de la Rosette J, Jones TH, Neijber D, Carrara D. A new 2% testosterone gel formulation: a comparison with currently available topical preparations. Andrology. 2018;6:396–407. doi:10.1111/andr.1248729600542
- Smith AB, Dickinson S, Arber M. P381: a pragmatic review of patient satisfaction and testosterone replacement therapy In: Society for Endocrinology BES 2015. Edinburgh: Endocrine Abstracts. 2015;37.
- Street DJ, Burgess L, Louviere JJ. Quick and easy choice sets: constructing optimal and nearly optimal stated choice experiments. Int J Res Mark. 2005;22(4):459–470. doi:10.1016/j.ijresmar.2005.09.003
- Greene WH, Hensher DA. A latent class model for discrete choice analysis: contrasts with mixed logit. Transport Res B Meth. 2003;37(8):681–698. doi:10.1016/S0191-2615(02)00046-2
- Whitty JA, Stewart S, Carrington MJ, et al. Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the which? trial. PLoS One. 2013;8(3):e58347. doi:10.1371/journal.pone.005834723505491